You are here

FTC

Antitrust Panel Sets Sights on Big Pharma for Next Target

Antitrust Panel Sets Sights on Big Pharma for Next Target

BioSpace

Flag link:

With FTC Nod, Stryker is Set to Close Wright Medical Deal

With FTC Nod, Stryker is Set to Close Wright Medical Deal

Medical Devices and Diagnostics Industry

Flag link:

Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit

Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit

Motley Fool

Flag link:

Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit

Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit

Endpoints

Vyera Pharmaceuticals

Flag link:

Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC

Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC

Endpoints

Flag link:

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Endpoints

Flag link:

AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go

AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go

Fierce Pharma

Flag link:

AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger

AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger

BioSpace

Flag link:

AbbVie, Allergan merger may face regulatory delay due to COVID-19: report

AbbVie, Allergan merger may face regulatory delay due to COVID-19: report

Fierce Pharma

Flag link:

The FDA and FTC Announce an Effort to Deter Anti-Competitive Practices Among Drugmakers

The FDA and FTC Announce an Effort to Deter Anti-Competitive Practices Among Drugmakers

Motley Fool

anti-competitive scheme

Flag link:

Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market

Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market

Stat

Vyera Pharmaceuticals

Flag link:

Roche's $4.8B deal for Spark cleared by FTC after long delay

Roche's $4.8B deal for Spark cleared by FTC after long delay

Biopharma Dive

Spark Therapeutics

Flag link:

82 Professors Call on Court to Support FTC Decision in Pay-for-Delay Case

82 Professors Call on Court to Support FTC Decision in Pay-for-Delay Case

RAPS.org

Endo Pharmaceuticals

Flag link:

After big M&A year, will pharma move away from massive deals in 2020?

After big M&A year, will pharma move away from massive deals in 2020?

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Disruptor of the Year: The Federal Trade Commission

Disruptor of the Year: The Federal Trade Commission

Biopharma Dive

Spark Therapeutics

Flag link:

Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday

Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday

Investors Business Daily

Bristol-Myers Squibb

Flag link:

FTC requests AbbVie, Allergan for more information on $63 billion deal

FTC requests AbbVie, Allergan for more information on $63 billion deal

Reuters

Flag link:

U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers

U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers

Reuters

Flag link:

[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug

[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug

Motley Fool

Bristol-Myers Squibb

Flag link:

Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?

Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?

Endpoints

Spark Therapeutics

Flag link:

Pages